NOVT — Novanta Inc.

Summary of Novanta Inc. Q1 2026 Earnings Call

1. Key Financial Results and Metrics

• Revenue Growth: Novanta reported a 10% increase in revenue year-over-year, with 3% organic growth.
• Bookings: Bookings surged by 37% year-over-year, resulting in a book-to-bill ratio of 1.10.
• Profitability: Adjusted EBITDA rose by 14% to $57 million, with an adjusted EBITDA margin of 22%, up 70 basis points from the previous year.
• Earnings Per Share: Adjusted diluted EPS increased by 9% to $0.81.
• Cash Flow: Operating cash flow improved significantly, up 63% year-over-year to $52 million, achieving over 200% cash flow conversion of net income.
• Debt Position: Gross debt stood at $249 million, with a net cash position of negative $139 million.

2. Strategic Updates and Business Highlights

• Market Segments: All business segments experienced double-digit bookings growth, with notable strength in Advanced Surgery and Robotics & Automation.
• Product Innovation: New product revenue increased by 50% year-over-year, with a Vitality Index at 27% of sales.
• Long-term Strategy: Novanta is focused on high-growth markets, including AI-driven Robotics & Automation, Precision Medicine, and digital manufacturing, with a target market opportunity of $4 billion by 2030.
• Acquisitions: The company is actively pursuing acquisitions to enhance its growth profile, with a strong pipeline of mid- to larger opportunities.

3. Forward Guidance and Outlook

• 2026 Guidance: Novanta raised its revenue guidance to approximately $1,040 million to $1,055 million, indicating reported growth greater than 7% and organic growth of up to 6%.
• Q2 2026 Expectations: Projected GAAP revenue for Q2 is between $259 million and $264 million, with organic growth of 6% to 8%. Adjusted EBITDA is expected to be between $58 million and $62 million.
• Margin Improvement: Anticipated gross margins for Q2 are approximately 45.5% to 46%, with expectations for stronger performance in the second half of the year.

4. Bad News, Challenges, or Points of Concern

• Margin Pressure: Adjusted gross margins decreased by 60 basis points year-over-year due to higher freight, tariff costs, and material costs from geopolitical dynamics.
• Geopolitical Risks: Ongoing trade dynamics and geopolitical tensions are being monitored closely, as they could impact future performance.
• Regional Sales Variability: Sales in the U.S. were down year-over-year, attributed to shifts in customer production locations rather than end-market demand.

5. Notable Q&A Insights

• Bookings vs. Revenue: Management clarified that while bookings were strong, there is typically a 2-3 quarter lag before these translate into revenue.
• GenAI Infrastructure: Approximately 15% of total revenue is now linked to GenAI infrastructure investments, with expectations for growth to accelerate.
• NVIDIA Partnership: The selection of Novanta as a partner in NVIDIA's AI Systems Inspection Lab enhances credibility and positions the company favorably in the robotics space, although significant revenue impact is expected to materialize in 2027.
• Tariff and Cost Dynamics: The recent rapid changes in tariff rates created unexpected cost pressures, but management is implementing price increases and surcharges to mitigate these impacts.

Overall, Novanta's Q1 2026 results reflect strong operational performance and strategic positioning in high-growth markets, despite facing challenges related to margin pressures and geopolitical uncertainties. The company remains optimistic about its growth trajectory and market opportunities.